CORGENIX MEDICAL CORP/CO (CONX) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 46 transactions totaling $16.1M, demonstrating a bearish sentiment with -$15.7M in net insider flow. The most recent transaction on May 1, 2024 involved a transaction of 18,750,000 shares valued at $0.
No significant insider buying has been recorded for CONX in the recent period.
No significant insider selling has been recorded for CONX in the recent period.
Based on recent SEC filings, insider sentiment for CONX is bearish with an Insider Alignment Score of 1/100 and a net flow of -$15.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CORGENIX MEDICAL CORP/CO (CONX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading CONX stock, having executed 46 transactions in the past 90 days. The most active insider is Capital Asset Management L.p. Jericho (Executive), who has made 1 transactions totaling $40.8M.
Get notified when executives and directors at CONX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 1, 2024 | W. Ergen Charles | Executive | Conversion | 18,750,000 | $N/A | $0 | |
| Apr 29, 2024 | Llc Mmf Lt, | Executive | Sale | 1,500,000 | $10.60 | $15.9M | Large |
| Jun 2, 2023 | Asset Management L.p. Jericho Capital | Executive | Other | 4,000,000 | $10.19 | $40.8M | Large |
| Mar 10, 2015 | Critchfield William | Executive | Disposition | 366,545 | $0.27 | $99.0K | |
| Mar 10, 2015 | P. Gouze Stephen | Executive | Disposition | 1,052,612 | $0.27 | $284.2K | |
| Mar 10, 2015 | Steinbarger Ann | Executive | Disposition | 187,855 | $0.27 | $50.7K | |
| Mar 10, 2015 | T. Simpson Douglas | Executive | Disposition | 435,838 | $0.27 | $117.7K | |
| Mar 10, 2015 | Stanley Tutag Robert | Executive | Disposition | 961,000 | $0.27 | $259.5K | |
| Oct 10, 2011 | Stanley Tutag Robert | Executive | Purchase | 750,000 | $0.10 | $75.0K | |
| Oct 10, 2011 | P. Gouze Stephen | Executive | Purchase | 1,050,612 | $0.10 | $105.1K | |
| Jul 14, 2011 | Critchfield William | Executive | Award | 64,543 | $0.08 | $5.2K | |
| Oct 8, 2010 | Stanley Tutag Robert | Executive | Purchase | 23,700 | $0.11 | $2.6K | |
| Oct 8, 2010 | Stanley Tutag Robert | Executive | Purchase | 3,000 | $0.11 | $330 | |
| Oct 8, 2010 | Stanley Tutag Robert | Executive | Purchase | 11,300 | $0.11 | $1.2K | |
| Oct 8, 2010 | Stanley Tutag Robert | Executive | Purchase | 2,000 | $0.11 | $220 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 2 | $40.9M | 70.5% |
Sale(S) | 1 | $15.9M | 27.4% |
Disposition(D) | 5 | $811.0K | 1.4% |
Purchase(P) | 25 | $241.2K | 0.4% |
Award(A) | 12 | $160.1K | 0.3% |
Conversion(C) | 1 | $0 | 0.0% |
Insider selling pressure at CORGENIX MEDICAL CORP/CO has increased, with 11 insiders executing 46 transactions across all time. Total sales of $15.9M significantly outpace purchases of $241.2K, resulting in a net outflow of $15.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.